Predictors of long-term disability accrual in relapse-onset multiple sclerosis-Reference-Cited by-同舟云学术

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

Published:2016-06-01 Issue:1 Volume:80 Page:89-100
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Jokubaitis Vilija G.¹²^ORCID,Spelman Tim¹,Kalincik Tomas¹²^ORCID,Lorscheider Johannes¹²,Havrdova Eva³,Horakova Dana³,Duquette Pierre⁴,Girard Marc⁴,Prat Alexandre⁴,Izquierdo Guillermo⁵,Grammond Pierre⁶,Van Pesch Vincent⁷,Pucci Eugenio⁸,Grand'Maison François⁹,Hupperts Raymond¹⁰,Granella Franco¹¹,Sola Patrizia¹²,Bergamaschi Roberto¹³,Iuliano Gerardo¹⁴,Spitaleri Daniele¹⁵,Boz Cavit¹⁶,Hodgkinson Suzanne¹⁷,Olascoaga Javier¹⁸,Verheul Freek¹⁹,McCombe Pamela²⁰,Petersen Thor²¹,Rozsa Csilla²²,Lechner-Scott Jeannette²³,Saladino Maria Laura²⁴,Farina Deborah²⁵,Iaffaldano Pietro²⁶,Paolicelli Damiano²⁶,Butzkueven Helmut¹²²⁷,Lugaresi Alessandra²⁸²⁹,Trojano Maria²⁶,

Affiliation:

1. Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital; University of Melbourne; Melbourne Victoria Australia

2. Department of Neurology; Royal Melbourne Hospital; Melbourne Victoria Australia

3. Department of Neurology and Center of Clinical Neuroscience; First Faculty of Medicine, General University Hospital and Charles University in Prague; Prague Czech Republic

4. Centre Hospitalier de l'Université de Montréal , Notre Dame Hospital; Montreal Quebec Canada

5. Hospital Universitario Virgen Macarena; Seville Spain

6. Centre de réadaptation déficience physique Chaudière-Appalache; Lévis Quebec Canada

7. Cliniques Universitaires Saint-Luc; Brussels Belgium

8. Neurology Unit, Azienda Sanitaria Unica Regionale Marche AV3; Macerata Italy

9. Neuro Rive-Sud, Charles LeMoyne Hospital; Greenfield Park Quebec Canada

10. Zuyderland Ziekenhuis; Sittard The Netherlands

11. University of Parma; Parma Italy

12. Nuovo Ospedale Civile S.Agostino/Estense; Modena Italy

13. C. Mondino National Neurological Institute; Pavia Italy

14. Ospedali Riuniti di Salerno; Salerno Italy

15. Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati; Avellino Italy

16. Karadeniz Technical University; Trabzon Turkey

17. Department of Neurology; Liverpool Hospital; Liverpool New South Wales Australia

18. Donostia Hospital; San Sebastián Spain

19. Groene Hart Ziekenhuis; Gouda The Netherlands

20. Centre for Clinical Research; University of Queensland; Brisbane Queensland Australia

21. Kommunehospitalet; Arhus C Denmark

22. Jahn Ferenc Teaching Hospital; Budapest Hungary

23. John Hunter Hospital; University of Newcastle; Newcastle New South Wales Australia

24. Instituto de Neurociencias Buenos Aires; Buenos Aires Argentina

25. MS Center, Department of Neuroscience, Imaging and Clinical Sciences; G. d'Annunzio University; Chieti Italy

26. Department of Basic Medical Sciences, Neuroscience and Sense Organs; University of Bari; Bari Italy

27. Department of Neurology, Box Hill Hospital; Monash University; Box Hill Victoria Australia

28. Department of Biomedical and Neuromotor Sciences (DIBINEM); Alma Mater Studiorum-University of Bologna; Bologna Italy

29. IRCCS Istituto delle Scienze Neurologiche di Bologna; Bologna Italy

Funder

National Health and Medical Research Council

NHMRC Centre for Research Excellence

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference47 articles.

1. Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta;Castrop;Neuropsychiatr Dis Treat,2013

2. Treatment Experience, Burden and Unmet Needs (TRIBUNE) in MS study: results from five European countries;Karampampa;Mult Scler,2012

3. Treatment Experience, Burden, and Unmet Needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada;Karampampa;J Popul Ther Clin Pharmacol,2012

4. The economic impact of multiple sclerosis in Australia in 2010;Palmer;Mult Scler,2013

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil/lymphocyte and monocyte/lymphocyte indexes as potential predictors of relapse at 1 year after diagnosis of pediatric multiple sclerosis: a single-center, exploratory and proof-of-concept study;Frontiers in Neuroscience;2024-01-15

2. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry;Journal of Neurology;2023-12-22

3. Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort;Journal of Neurology;2023-12-12

4. Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options;Autoimmunity Reviews;2023-11

5. Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis;JAMA Neurology;2023-11-01